COVID-19
Conditions
Interventions
CGA Intervention Group?:1. Comprehensive medical evaluation
2. Nutritional assessment and intervention
3. Physical function assessment and intervention
4. Cognitive and psychological function assessment and intervention
5. Social and environmental assessment interventions
6. Standard treatment in accordance with the Novel Coronavirus Infection Prevention and Control Protocol (10th Edition).
Control group:Standard treatment is performed according to the novel coronavirus infection Prevention and Control Protocol (Version 10)
Standard treatment group:Standard treatment is performed according to the novel coronavirus infection Prevention and Control Protocol (Version 10)
CGA Intervention Group ?:1. Comprehensive medical evaluation
Control Group and CGA Intervention Group:1. Standard treatment in accordance with the Novel Coronavirus Infection Prevention and Control Protocol (10th Edition)
2. Use of high-flow assisted ventilation, glucocorticoids, tocilizumab or baricitinib within 48 hours of admission
Intensive treatment CGA intervention group:1. Comprehensive medical evaluation
Sponsors
The Second Hospital of Nanjing
Eligibility
Sex/Gender
All
Age
60 Years to No maximum
Inclusion criteria
Inclusion criteria: Part ?: (1) Age >=60 years old; (2) The diagnostic criteria for novel coronavirus pneumonia in the tenth version of the protocol were met upon admission; (3) Standard treatment in accordance with the tenth version of the program during hospitalization; (4) Complete a full set of CGA with complete medical records. Part ?: (1) Meet the diagnostic criteria for novel coronavirus pneumonia in the 10th edition of the plan; (2) Age>=60 years old; (3) estimated survival time>=3 months; (4) Clear, normal language skills, able to complete a full set of CGA; (5) Voluntarily accept this pilot study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: Part ?: (1) Age <60 years old; (2) Did not meet the diagnostic criteria for novel coronavirus pneumonia in the tenth version of the protocol at admission; (3) Standard treatment in accordance with the tenth version of the program during hospitalization; (4) Complete medical records are not available. Part ?: (1) Expected survival time < 3 months and unable to benefit from CGA; (2) Completely dependent, or cognitive impairment, or unable to complete the full CGA for other reasons; (3) Serious primary diseases that may affect patient participation in the trial or influence research outcomes, such as heart, kidney, lung, endocrine, blood, metabolic, or gastrointestinal diseases; (4) Participation in other clinical trials within the last 3 months before enrollment; (5) Inability to obtain complete medical records; (6) Cannot adhere to the prescribed treatment or has not completed the observation period for any reason; (7) Other conditions as judged by the investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nutritional Status Assessment Scale;Physical Function Assessment Scale;Cognitive Score;Anxiety and Depression Score;BMI;Oxyhemoglobin saturation;White Blood Cell Count;Lymphocyte Count;Procalcitonin;C-Reactive Protein;CD4 T Lymphocytes;Chest CT Report; | — |
Countries
China
Contacts
Public ContactYan Gu
The Second Hospital of Nanjing
Outcome results
None listed